Effects of glucocorticoids on radiological progression in rheumatoid arthritis.
暂无分享,去创建一个
[1] M Cutolo,et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data , 2005, Annals of the rheumatic diseases.
[2] R. Rau,et al. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial. , 2005, Arthritis and rheumatism.
[3] A. Boonen,et al. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial. , 2005, Arthritis and rheumatism.
[4] B. Dijkmans,et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. , 2005, Arthritis and rheumatism.
[5] G. Kingsley,et al. A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs , 2005, Annals of the rheumatic diseases.
[6] R. Madhok,et al. Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial , 2004, Annals of the rheumatic diseases.
[7] E. Nasonov,et al. [Effect of small-dose glucocorticoids on the course of early rheumatic arthritis]. , 2004, Klinicheskaia meditsina.
[8] G. Jones,et al. The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebo-controlled trials. , 2003, Rheumatology.
[9] Rene Westhovens,et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. , 2002, Arthritis and rheumatism.
[10] J. Jacobs,et al. Low-Dose Prednisone Therapy for Patients with Early Active Rheumatoid Arthritis: Clinical Efficacy, Disease-Modifying Properties, and Side Effects: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial , 2002, Annals of Internal Medicine.
[11] J. Kirwan. Links between radiological change, disability, and pathology in rheumatoid arthritis. , 2001, The Journal of rheumatology.
[12] J. Kirwan,et al. The relationship between soft tissue swelling, joint space narrowing and erosive damage in hand X-rays of patients with rheumatoid arthritis. , 2001, Rheumatology.
[13] A Woolf,et al. The links between joint damage and disability in rheumatoid arthritis. , 2000, Rheumatology.
[14] M. Suarez‐Almazor,et al. Moderate-term, low-dose corticosteroids for rheumatoid arthritis. , 1998, The Cochrane database of systematic reviews.
[15] J. Pødenphant,et al. A randomised trial of differentiated prednisolone treatment in active rheumatoid arthritis. Clinical benefits and skeletal side effects , 1999, Annals of the rheumatic diseases.
[16] J. Kirwan,et al. Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group. , 1998, British journal of rheumatology.
[17] S. van der Linden,et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis , 1997, The Lancet.
[18] D. Schwartz,et al. Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. , 1996, Arthritis and rheumatism.
[19] J. Kirwan,et al. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. , 1995, The New England journal of medicine.
[20] L. V. D. van de Putte,et al. Oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomized double-blind placebo-controlled trial. , 1995, British journal of rheumatology.
[21] A. Zwinderman,et al. Prednisone treatment of elderly-onset rheumatoid arthritis. Disease activity and bone mass in comparison with chloroquine treatment. , 1995, Arthritis and rheumatism.
[22] Diana B. Petitti,et al. Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine , 1994 .
[23] M. Weisman. Should steroids be used in the management of rheumatoid arthritis? , 1993, Rheumatic diseases clinics of North America.
[24] T. Pincus,et al. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone. , 1992, The Journal of rheumatology.
[25] J. Sibley,et al. Steroids in rheumatoid arthritis: the honeymoon revisited. , 1992, The Journal of rheumatology.
[26] D. Furst,et al. The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis. , 1991, Seminars in arthritis and rheumatism.
[27] D. Felson,et al. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. , 1990, Arthritis and rheumatism.
[28] P. Kryger,et al. Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis. , 1990, BMJ.
[29] David T. Felson,et al. THE COMPARATIVE EFFICACY AND TOXICITY OF SECOND LINE DRUGS IN RHEUMATOID ARTHRITIS , 1990 .
[30] M. Weiss. Corticosteroids in rheumatoid arthritis. , 1989, Seminars in arthritis and rheumatism.
[31] J. Edmonds,et al. HLA-B27, molecular mimicry, and ankylosing spondylitis: popular misconceptions. , 1987, Annals of the rheumatic diseases.
[32] J. Kirwan,et al. Corticosteroids in rheumatoid arthritis: is a trial of their 'disease modifying' potential feasible? , 1986, Annals of the rheumatic diseases.
[33] L. Hedges,et al. Statistical Methods for Meta-Analysis , 1987 .
[34] A. Mowat,et al. Corticosteroid prescribing in rheumatoid arthritis--the fiction and the fact. , 1985, British journal of rheumatology.
[35] A. Newberg,et al. Low dose prednisone therapy in rheumatoid arthritis: a double blind study. , 1983, The Journal of rheumatology.